Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Peripheral Venous Pressure–Guided Care in Heart Failure

Official title: Reducing the Length of Stay and Incidence of Rehospitalization in Heart Failure Patients by Measuring Peripheral Venous Pressure; a Randomized Clinical Trial

Run by Wake Forest University Health Sciences · NCT07400042 · Data updated 2026-11-12

In people with congestive heart failure, this study tests whether daily peripheral venous pressure measurements, used to guide treatment, can shorten hospital stays and reduce readmissions compared with standard care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment600 (estimated)
SponsorWake Forest University Health Sciences
Academic / other
Locations1 site (Milwaukee, Wisconsin)
StatusRecruiting
StartedOctober 5, 2026
Main results expectedOctober 2031
Study endsOctober 2031
Registry record updatedOctober 7, 2026
Trial IDNCT07400042 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking adults with a minimum 3-month history of congestive heart failure admitted for acute decompensation and with an existing IV line.

Probably not a fit

Patients without an IV line, those with recent major cardiovascular events, or those enrolled in other cardiovascular studies may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention compares standard clinical care to care guided by daily peripheral venous pressure measurements in hospitalized heart failure patients with acute decompensation. Researchers will track length of stay, 30-day rehospitalization, and 6-month rehospitalization, along with symptoms, lab values, diuretic use, and imaging needs. The study is conducted at Aurora St. Luke's Medical Center and led by Wake Forest University Health Sciences. It is an interventional study without a specified phase. Participation requires an existing IV line and English-speaking status, among other safety criteria.

Why it matters

Potential benefit: If successful, patients may have shorter hospital stays and fewer readmissions.

How similar studies have gone: Previous work in related hemodynamic-guided care shows potential benefits, but this specific PVP-guided approach is novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with minimum 3-month history of Congestive Heart Failure admitted to Aurora St. Luke's Medical Center with acute decompensation
* English speaking only

Exclusion Criteria:

* Patients who do not already have a peripheral IV line inserted
* Patients whose IV line cannot be transduced
* Patients with current or past vein thrombosis in the arm used to measure the pressure or with history of recurrent (\>1) pulmonary embolism
* Patients with active thrombophlebitis in the arm
* Patients who have experienced a major cardiovascular event (myocardial infarction, stroke, etc.) ≤2 months prior to the admission date
* Patients who have received an implanted cardiac resynchronization device (pacemaker or ICD) ≤3 months prior to admission date
* Patients enrolled in other cardiovascular research studies.
* Patients with a clinical condition that the investigator believes may not allow the patient to complete the study, at the discretion of the investigator. Examples of conditions that may apply include severe stenotic valvular disease, isolated right ventricle failure, precapillary pulmonary hypertension, hypertrophic obstructive cardiomyopathy, implanted left ventricular assist device, history of heart transplantation, clinical diagnosis of cardiogenic shock, any left-to-right shunt
* Patients with congenital heart disease or mechanical right heart valve(s)
* Planned heart surgery and/or coronary intervention during hospitalization
* Patients expected to receive heart transplant within 6 months of admission
* IV cannula smaller than 22G
* Patients who are pregnant and/or lactating
* Patients who are unable to provide informed consent
* Patients who are intubated

Where it's running

  • Aurora St. Luke's Medical Center
    Milwaukee, Wisconsin, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.